ASCO Launches Its First-ever Clinical Trial
June 9, 2015
The American Society of Clinical Oncology (ASCO) today announced its first-ever clinical trial that will offer patients with advanced cancer access to molecularly-targeted cancer drugs and collect “real-world” data on clinical outcomes to help learn the best uses of these drugs outside of indications approved by the Food and Drug Administration (FDA). Plans for the [...]
Omicia Wins UK’s 100,000 Genomes Project as Clinical Interpretation Provider
June 9, 2015
OAKLAND, Calif.--Omicia, the leading clinical genomics company, today announced that it has been selected by Genomics England to provide clinical interpretation services for the 100,000 Genomes Project. For the first phase of the project Illumina will provide sequencing services, while Omicia will provide interpretation and clinical reports. Genomics England leads the UK’s national initiative to [...]
Twist Bioscience Raises $37 Million In Oversubscribed Series C Financing
June 9, 2015
SAN FRANCISCO -- Twist Bioscience, a company focused on synthetic DNA, today announced the completion of a $37 million Series C financing. Led by Illumina, Inc., participants in the round include new investors Fidelity Management and Research Company and Foresite Capital Management LLC, as well as all existing investors including Nick and Joby Pritzker (through [...]
Green Chemistry hits full flow with China UK partnership
June 9, 2015
Vapourtec (Suffolk, UK) has recently signed a pioneering, 3 year agreement with Nanjing University of Technology (NJUT) in China to establish a joint operation in the fast growing, hi tec field of flow chemistry. The partnership involves the establishment of a dedicated flow chemistry research lab at the Chinese university officially named 'Vapourtec and Tegent [...]
Luminex Corporation Begins Clinical Trials for ARIES™ GBS Assay
June 8, 2015
AUSTIN, Texas -- Luminex Corporation (NASDAQ: LMNX) today announced that it has commenced clinical and analytical studies to evaluate the company's ARIES™ Group B Streptococcus (GBS) Assay. ARIES System "We continue to build momentum in our commercial launch schedule for the ARIES platform with the start of clinical trials for GBS, the third assay in [...]
June 8, 2015
Merck KGaA and Illumina said today they are partnering with Genea to improve fertility-related technologies and processes within assisted reproductive treatment (ART) labs. The partnership, called the Global Fertility Alliance, is designed to improve ART consistency worldwide and addresses the need for more standardization of fertility processes within ART labs. The companies will formally launch [...]
Novasep signs two deals to further develop its presence in Japan
June 8, 2015
Pompey, France - Novasep, a leading supplier of services and technologies for the life sciences and chemical industries today announces it is expanding its presence in Asia by signing two partnership agreements for the Japanese market. The first agreement was signed with Allied Laboratories, a life science and chemical consulting company. Allied Laboratories now provides [...]
Agilent Technologies Launches Updated Gene Expression Microarrays for Human, Mouse and Rat Models
June 8, 2015
SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today announced updates to its SurePrint gene expression microarrays for messenger RNA profiling applications for human, mouse and rat models. The updates improve coding and noncoding content, which will provide up-to-date tools for researchers to investigate expression patterns on a highly accessible platform. Agilent developed the [...]
Fluidic Analytics receives £250k funding award
June 8, 2015
Fluidic Analytics is a spin-out from the University of Cambridge that is developing products based on a disruptive technology for protein characterisation. Proteins are the direct, real-time indicators of the state of a biological system. While DNA gives information about how people and organisms will develop over their entire lifetimes, proteins give information about how [...]
June 8, 2015
REDWOOD CITY, California, and FALLS CHURCH, Virginia -– QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) and Inova Translational Medicine Institute (ITMI) today announced the commercial launch of Inova Genomes, a unique compendium of ethnically, phenotypically, and ancestrally diverse whole-genome sequencing data for researchers seeking to accelerate cohort analysis programs or improve success rates in [...]
